By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

NeurAxis, Inc. (NRXS)

NASDAQ Currency in USD
$2.42
-$0.02
-0.82%
Last Update: 11 Sept 2025, 20:00
$23.87M
Market Cap
-2.35
P/E Ratio (TTM)
Forward Dividend Yield
$1.33 - $6.20
52 Week Range

NRXS Stock Price Chart

Explore NeurAxis, Inc. interactive price chart. Choose custom timeframes to analyze NRXS price movements and trends.

NRXS Company Profile

Discover essential business fundamentals and corporate details for NeurAxis, Inc. (NRXS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

9 Aug 2023

Employees

21.00

CEO

Brian Carrico

Description

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

NRXS Financial Timeline

Browse a chronological timeline of NeurAxis, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 12 Aug 2025

EPS came in at -$0.22 , while revenue for the quarter reached $894.09K .

Earnings released on 12 May 2025

EPS came in at -$0.31 falling short of the estimated -$0.24 by -29.17%, while revenue for the quarter reached $895.66K .

Earnings released on 20 Mar 2025

EPS came in at -$0.21 , while revenue for the quarter reached $761.17K .

Earnings released on 12 Nov 2024

EPS came in at -$0.25 , while revenue for the quarter reached $666.63K .

Earnings released on 9 Aug 2024

EPS came in at -$0.42 , while revenue for the quarter reached $611.50K .

Earnings released on 20 May 2024

EPS came in at -$0.32 , while revenue for the quarter reached $646.64K .

Earnings released on 16 Apr 2024

EPS came in at $0.29 , while revenue for the quarter reached $531.46K .

Earnings released on 20 Nov 2023

EPS came in at -$1.06 falling short of the estimated -$0.17 by -523.53%, while revenue for the quarter reached $477.46K .

Earnings released on 18 Aug 2023

EPS came in at -$0.37 , while revenue for the quarter reached $646.02K .

Earnings released on 11 Aug 2023

EPS came in at -$0.35 , while revenue for the quarter reached $805.11K .

Earnings released on 31 Dec 2022

EPS came in at -$0.00 , while revenue for the quarter reached $613.08K .

Earnings released on 30 Sept 2022

EPS came in at -$0.25 , while revenue for the quarter reached $618.81K .

Earnings released on 30 Jun 2022

EPS came in at -$0.18 , while revenue for the quarter reached $682.58K .

Earnings released on 31 Mar 2022

EPS came in at -$0.10 , while revenue for the quarter reached $770.27K .

Earnings released on 31 Dec 2021

EPS came in at -$0.16 , while revenue for the quarter reached $466.77K .

NRXS Stock Performance

Access detailed NRXS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run